Efforts to optimize the delivery of sensitive biotherapeutics continue to evolve.

Safeguarding Biologics

Appreciating the full impact certain select technologies will make on the industry by 2026.

Six Approaches Significantly Impacting in the Future

Unique dosage forms, personalized medicine, and flexible manufacturing are possible with 3DP.

Moving Forward with GMP 3D Printing

Topic

Feliza Mirasol is the science editor for 

Articles

Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.

Samsung Biologics to Build Plant 5 as Part of Capacity Expansion to Bio Campus II

Podcasts

Adam C. Fisher, PhD, director of Science Staff and Immediate Office/Office of Pharmaceutical Quality at the Center for Drug Evaluation and Research/FDA, discusses point of care and patient manufacturing with Pharmaceutical Technology editor Jill Murphy. 

Drug Solutions Podcast: Point of Care and Patient Manufacturing 

Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.

Stevanato Group and Recipharm to Collaborate on Pre-fillable Syringes for Soft Mist Inhaler

Webcasts

Webinar Date/Time: Tue, Apr 18, 2023 11:00 AM EDT


Modern Modelling Tools for Small Molecule Solid Dose Manufacturing

Sandoz, a Novartis division, is expected to invest at least $400 million to build a new biologics manufacturing facility in Lendava, Slovenia, to support growing demand for biosimilars.

Sandoz to Build New Biologics Production Facility in Slovenia

Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.

Catalent Licenses Bhami Research Laboratory Technology for Biologics Formulation Development

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

Manual aseptic operations make quality practices necessary in the manufacturing of compounded drugs.

Quality Considerations for the Manufacture of Compounded Drugs

Catalent is expanding its UpTempo AAV platform to accelerate the development of gene therapies. 

Catalent Expands UpTempo AAV Platform 

Webinar Date/Time: Tuesday, April 4th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST


A Practical Road Map for Compliance to the Container Closure Requirements in the New EU GMP Annex 1

Actylis new 30,000-ft² API manufacturing facility is located in Eugene, Ore.

Actylis Opens 30,000-square-foot API Manufacturing Facility

Aseptic/Sterile Processing

Cleanroom Equipment and Supplies

Clinical Trial Materials

Equipment

Facility Design and Engineering

Fill-Finish

Information Technology

Manufacturing Equipment, Biologics

Manufacturing Equipment, Downstream Processing

Manufacturing Equipment, Fill-Finish

Manufacturing Equipment, Solid Dose Drugs

Manufacturing Equipment, Upstream Processing

Manufacturing Services

Manufacturing Systems, Single-Use

Manufacturing, Biologic Drugs

Manufacturing, Biosimilars and Biobetters

Manufacturing, Cell Culture and Fermentation

Manufacturing, Cell Therapies

Manufacturing, Cell-Line Selection

Manufacturing, Combination Drugs

Manufacturing, Continuous Solid Dosage Processing

Manufacturing, Drug Products

Manufacturing, Expression Systems

Manufacturing, Gene Therapies

Manufacturing, Inhalation Drugs

Manufacturing, Liquid Drug Products

Manufacturing, Lyophilization

Manufacturing, Nucleic Acids

Manufacturing, Parenterals and Injectables

Manufacturing, Process Chromatography

Manufacturing, Recombinant Proteins

Manufacturing, Separation and Purification

Manufacturing, Solid Dosage Drugs

Manufacturing, Specialty Dosage Forms

Manufacturing, Topical Drugs

Manufacturing, Vaccines

Packaging Trends

Packaging, Labeling, and Distribution Systems

PharmTech Products

Process Control, Automation, and PAT

Supply Chain

Technology Transfer

Viral Clearance

Manufacturing